Cargando…
Evidence of a founder BRCA1 mutation in Scotland
BRCA1 mutations have been identified in breast and ovarian cancer families from diverse ethnic backgrounds. We studied 17 different families with the BRCA1 2800delAA mutation; seven were ascertained in Scotland (Dundee, Edinburgh, Glasgow, St Andrews), five in Canada (Toronto, Victoria) and five in...
Autores principales: | Liede, A, Cohen, B, Black, D M, Davidson, R H, Renwick, A, Hoodfar, E, Olopade, O I, Micek, M, Anderson, V, Mey, R De, Fordyce, A, Warner, E, Dann, J L, King, M-C, Weber, B, Narod, S A, Steel, C M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363321/ https://www.ncbi.nlm.nih.gov/pubmed/10682686 http://dx.doi.org/10.1054/bjoc.1999.0984 |
Ejemplares similares
-
BRCA1 founder mutations compared to ovarian cancer in Belarus
por: Savanevich, Alena, et al.
Publicado: (2014) -
Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
por: Kluz, Tomasz, et al.
Publicado: (2018) -
Identification of a founder BRCA2 mutation in Sardinia
por: Pisano, M, et al.
Publicado: (2000) -
The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel
por: Vazina, A, et al.
Publicado: (2000) -
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
por: Maksimenko, J., et al.
Publicado: (2018)